SIRELIS Trademark
SIRELIS is a USPTO trademark filed by Alnylam Pharmaceuticals, Inc.. Status: Pending.
Trademark Facts
| Mark | SIRELIS |
|---|---|
| Serial Number | 99555535 |
| Status | Pending |
| Filing Date | 2025-12-18 |
| Mark Type | Word |
| Nice Classes | 040 (Material Treatment), 042 (Software & IT) |
| Owner | Alnylam Pharmaceuticals, Inc. |
| Attorney of Record | Sarah Anne Keefe |
| Prosecution Events | 7 |
| Latest Event | GNRT on 2026-04-22 |
Goods & Services
Class 040: Providing technical information in the field of pharmaceutical manufacturing; Manufacturing services for others in the field of siRNA synthesis; Custom manufacture of siRNA therapeutics; Custom manufacture of RNA utilizing proprietary enzymatic technologies to enable nucleic acid therapeutics development; Class 042: Scientific research and development; Research and development of small molecule RNA drugs; Research and development of siRNA drugs; RNA interference technology research
Recent Prosecution Activity
| Date | Document | Type |
|---|---|---|
| 2026-04-22 | Non-Final Action | NFIN |
| 2026-04-22 | Notice of Non-Final Office Action | NFO |
USPTO Refusals on Record
- indefinite_identification